However, work from the Lu group on the role of SLFN5 in breast cancer cells shows that SLFN5 could be considered a tumor suppressor in the context of TNBC by inhibiting the aggressiveness commonly seen by TNBC [27,29,30]. The gene discussed is SLFN5; the disease is breast carcinoma.